Burt Wealth Advisors’s Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible PPHMP Stock Holding History

Burt Wealth Advisors’s Portfolio PPHMP Stock Details PPHMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-600	Closed	-$12K	–	410
2016 Q4	$12K	Hold	600	–	–	0.01%	271
2016 Q3	$13K	Hold	600	–	–	0.01%	253
2016 Q2	$10K	Hold	600	–	–	0.01%	268
2016 Q1	$11K	Hold	600	–	–	0.01%	319
2015 Q4	$13K	Hold	600	–	–	0.01%	252
2015 Q3	$11K	Hold	600	–	–	0.01%	245
2015 Q2	$14K	Hold	600	–	–	0.02%	237
2015 Q1	$13K	Buy	+600	New	+$12.9K	0.01%	223

Other funds holding PPHMP

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Burt Wealth Advisors's PPHMP Position: Q1 2017 in Review

Burt Wealth Advisors sold out of Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible (PPHMP) in Q1 2017, closing a stake of 600 shares — an estimated $12K sold.

Burt Wealth Advisors first reported a position in PPHMP in Q1 2015 and held it in 8 quarters. The position peaked at $14K in Q2 2015. 1 fund tracked by Wall St. Rank holds PPHMP as of Q1 2017.

Burt Wealth Advisors reported no remaining Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible position as of Q1 2017 after selling out during the quarter.
Burt Wealth Advisors sold 600 Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible shares in Q1 2017, an estimated $12K.
Burt Wealth Advisors first reported a position in Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible in Q1 2015 and held it in 8 quarters.
Burt Wealth Advisors's Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible position peaked at $14K in Q2 2015.
1 fund tracked by Wall St. Rank held Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible as of Q1 2017.

Based on Burt Wealth Advisors's 13F filing for Q1 2017, filed 28 Apr 2017.